135
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

, , , , , , , & show all
Pages 1385-1392 | Accepted 18 Jun 2004, Published online: 16 Jul 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Madhuri Devabhaktuni & Sripal Bangalore. (2009) Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives. Vascular Health and Risk Management 5, pages 377-387.
Read now
Stella S. Daskalopoulou & Dimitri P. Mikhailidis. (2006) Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Current Medical Research and Opinion 22:3, pages 511-528.
Read now

Articles from other publishers (8)

Emilia Siemińska, Przemysław Sobczak, Natalia Skibińska & Joanna Sikora. (2020) The differential role of uric acid – The purpose or cause of cardiovascular diseases?. Medical Hypotheses 142, pages 109791.
Crossref
Allan D. Sniderman, Jacqueline De Graaf & Patrick Couture. (2012) Low-density lipoprotein-lowering strategies. Current Opinion in Cardiology 27:4, pages 405-411.
Crossref
Allan Sniderman, George Thanassoulis, Patrick Couture, Ken Williams, Ahsan Alam & Curt D. Furberg. (2012) Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists? Collaboration meta-analysis for low-density lipoprotein lowering. Journal of Clinical Lipidology 6:4, pages 303-309.
Crossref
Jian Huang, Roy Parish, Ishak Mansi, Herbert YuEstela M. Kennen, Terry Davis & Donna Carden. (2023) Non-High-Density Lipoprotein Cholesterol in Patients with Metabolic Syndrome. Journal of Investigative Medicine 56:7, pages 931-936.
Crossref
Renato Razzolini, Giuseppe Tarantini, Giovanni Ossena, Enrico Favaretto, Claudio Bilato, Enzo Manzato, Sergio Dalla-Volta & Sabino Iliceto. (2008) Non-Cardiovascular Mortality, Low-Density Lipoprotein Cholesterol and Statins: A Meta-Regression Analysis. Cardiology 109:2, pages 110-116.
Crossref
Vasilios G. Athyros, Anna I. Kakafika, Athanasios A. Papageorgiou, Konstantinos Tziomalos, Athanasios Skaperdas, Efstathios Pagourelias, Athina Pirpasopoulou, Asterios Karagiannis & Dimitri P. Mikhailidis. (2007) Atorvastatin Decreases Triacylglycerol-Associated Risk of Vascular Events in Coronary Heart Disease Patients. Lipids 42:11, pages 999-1009.
Crossref
Michael Piorkowski, Sabine Fischer, Caroline Stellbaum, Markus Jaster, Peter Martus, Andreas J. Morguet, Heinz-Peter Schultheiss & Ursula Rauch. (2007) Treatment With Ezetimibe Plus Low-Dose Atorvastatin Compared With Higher-Dose Atorvastatin Alone. Journal of the American College of Cardiology 49:10, pages 1035-1042.
Crossref
Sofia G. Tsouli, Evagelos N. Liberopoulos, Dimitrios N. KiortsisDimitri P. Mikhailidis & Moses S. Elisaf. (2016) Combined Treatment With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: A Review of the Current Evidence. Journal of Cardiovascular Pharmacology and Therapeutics 11:1, pages 1-15.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.